Regulation of FFA 3 transport across the cardiomyocyte membrane is essential for cardiovascular health and dysregulation may result in myocardial lipotoxicity (1). However, the mechanisms governing FFA transport across cell membranes are not well understood (2, 3). Proposed mechanisms include rapid flip-flop through the lipid phase of the plasma membrane (4) or a protein-mediated mechanism (2, 3, 5). Proteins reported to be correlated with FFA transport in cardiac or muscle cells include FAT/CD36, FABPpm, and FATP4 (6 -10).In previous studies of FFA transport we found virtually identical characteristics in adipocytes and preadipocytes, suggesting involvement of an unknown protein because FAT/ CD36, FABPpm, and FATP4 are expressed poorly or not at all in preadipocytes (2, 11-13). Transport in these studies was observed by imaging the concentration of intracellular unbound FFA (FFA i ) (11,12,14). This allowed us to directly monitor the movement of unbound FFA (FFA u ) from the extracellular medium and into the cytosol.Because FFA transport plays a vital role in the heart and because our adipocyte/preadipocyte results raise the possibility that novel FFA transport mechanisms might exist in other tissues, we have investigated FFA transport in cardiomyocytes isolated from wild type (WT) adult C57BL/6 mice and FAT/ CD36 Ϫ/Ϫ mice on the C57BL/6 background. We used several methods to monitor FFA transport in this study, so that key findings were confirmed independently of a specific method. These methods included 1) quantitative imaging of FFA i using a sensor of FFA, ADIFAB (acrylodan-labeled rat intestinal fatty acid-binding protein), 2) using the pH indicator BCECF-AM (2Ј,7Ј-bis(2-carboxyethyl)-5-(and-6)-carboxyfluorescein, acetoxymethyl ester) to monitor FFA influx and efflux, and 3) a new method to determine FFA uptake by monitoring the extracellular unbound FFA concentration (FFA o ) using ADIFAB in the extracellular medium.This study provides the first measurements of FFA i in cardiac cells and the first direct measurements of FFA influx and efflux across the cardiac plasma membrane. The results suggest that FFAs are pumped into cardiomyocytes and that FAT/CD36 interacts with the transporter/pump so that it significantly modifies the rate of efflux and, to a lesser extent, the rate of influx. The results significantly alter current views of the mechanisms of FFA transport in cardiac myocytes and may provide insights for understanding the role of FFA in cardiac dysregulation.
EXPERIMENTAL PROCEDURES